Survival and thalassaemia‐related complications in HbE /beta‐thalassaemia and alpha‐thalassaemia: A 10‐year longitudinal study in Thailand
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20179 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Nattiya Teawtrakul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: beta-Thalassemia, alpha-Thalassemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Khon Kaen University.
Abstract (Originalsprache)
Despite advancements in thalassaemia care, survival rates and complications vary significantly by genotype. This study assesses survival outcomes and associated complications in patients with thalassaemia in north‐eastern Thailand. A longitudinal cohort study from October 2012 to September 2023 involved patients aged ≥10 years (median: 31 years, range: 20–74) attending Srinagarind and Udonthani Hospitals. Cox regression analyses identified predictors of survival and complications. Of 380 enrolled patients, 340 completed follow‐up. Over 10 years, 39 patients (11.4%) died, primarily from cardiovascular complications (61.5%), at a median age of 45 years (range: 22–72). Patients were grouped as HbE/β‐thalassaemia, HbH/HbHCS with HbE mutation and HbH/HbHCS. Survival at 60 years was lower in HbE/β‐thalassaemia (55.9%) and HbH/HbHCS with HbE mutation (58.3%) compared to HbH/HbHCS (79.6%, p = 0.08). Significant predictors of mortality included cardiovascular complications (HR 2.4; 95% CI, 1.01–5.5; p = 0.04), recurrent bacterial infections (HR 7.6; 95% CI, 3.1–18.8; p < 0.001) and elevated ferritin (>2500 ng/mL; HR 2.0; 95% CI, 1.01–3.9; p = 0.04). Cardiovascular complications, recurrent bacterial infections and high ferritin levels significantly influence survival in thalassaemia patients. Deletional alpha‐thalassaemia patients had superior survival, while HbE/β‐thalassaemia and non‐deletional alpha‐thalassaemia or co‐inherited HbE mutation had poorer outcomes, underscoring the need for genotype‐specific management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Division of Hematology, Department of Pediatrics, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Hematology Unit, Udonthani Hospital, Udonthani, Thailand.
- Center for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Science, Khon Kaen University, Khon Kaen, Thailand.
ORCID-Profile: Nattiya Teawtrakul
Förderung
- Khon Kaen University
Zitieren
APA
Teawtrakul, N., Jetsrisuparb, A., Pongudom, S., Chansung, K., Sirijerachai, C., & Fucharoen, S. (2025). Survival and thalassaemia‐related complications in HbE /beta‐thalassaemia and alpha‐thalassaemia: A 10‐year longitudinal study in Thailand. British Journal of Haematology. https://doi.org/10.1111/bjh.20179
Vancouver
Teawtrakul N, Jetsrisuparb A, Pongudom S, Chansung K, Sirijerachai C, Fucharoen S. Survival and thalassaemia‐related complications in HbE /beta‐thalassaemia and alpha‐thalassaemia: A 10‐year longitudinal study in Thailand. British Journal of Haematology. 2025. doi:10.1111/bjh.20179
BibTeX
@article{Teawtrakul2025,
author = {Teawtrakul, Nattiya and Jetsrisuparb, Arunee and Pongudom, Saranya and Chansung, Kanchana and Sirijerachai, Chittima and Fucharoen, Supan},
title = {Survival and thalassaemia‐related complications in HbE /beta‐thalassaemia and alpha‐thalassaemia: A 10‐year longitudinal study in Thailand},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20179}
}
EUVIMED